The policy changes forbid insurers from saddling patients with out-of-pocket costs for services associated with lung and breast cancer.

The college believes the move will sow confusion and is asking the agency to rescind its noncoverage determination. 

Twenty-five state societies have voiced their support for the proposal, being presented at the 2023 ACR Annual Meeting in D.C. 

“These evidence-based updates should spur more-informed doctor-patient conversations and help providers save more lives," the document's lead author said. 

James McGuckin, MD, allegedly submitted more than 500 false claims for unnecessary vascular procedures between 2016 to 2019, the DOJ said.

Richard E. Heller, MD, MBA, the company's associate CMO for health policy and communications, detailed his thoughts in a recently published editorial.

“Quantib Prostate 3.0” offers a suite of tools to help radiologists and urologists improve the quality of their assessments.

The Nanox.ARC utilizes novel, cold-cathode X-ray tubes and charges physicians using a “pay per scan” business model.